PMID- 28000843 OWN - NLM STAT- MEDLINE DCOM- 20170316 LR - 20171116 IS - 1791-244X (Electronic) IS - 1107-3756 (Linking) VI - 39 IP - 2 DP - 2017 Feb TI - Wheat-bran autolytic peptides containing a branched-chain amino acid attenuate non-alcoholic steatohepatitis via the suppression of oxidative stress and the upregulation of AMPK/ACC in high-fat diet-fed mice. PG - 407-414 LID - 10.3892/ijmm.2016.2831 [doi] AB - Whole-wheat intake is known to reduce the risk of metabolic syndrome. However, the active component remains unclear. Recently, we identified bioactive peptides [leucine-arginine-proline (LRP) and leucine-glutamine‑proline (LQP)] from wheat bran autolytic hydrolysate. The present study aimed to investigate the effects of LRP and LQP on non-alcoholic steatohepatitis (NASH) in a mouse model. We also evaluated the effects of these peptides on oxidative stress and on the AMP-activated protein kinase (AMPK) signaling pathway, two major pathogenic factors of NASH. Seven‑week-old male C57BL/6 mice were fed a high-fat diet for 10 weeks and administered water supplemented with 0.05% LRP, 0.20% LRP, 0.05% LQP, or 0.20% LQP (each n=5) or distilled water (control; n=5) ad libitum. Oxidative stress was evaluated by measuring the serum levels of diacron reactive oxygen metabolite (d-ROM) and biological antioxidant potential (BAP). Hepatic expression of phosphorylated AMPK and phosphorylated acetyl-CoA carboxylase (ACC) were evaluated by immunoblotting. The result showed that non‑alcoholic fatty liver disease activity score was significantly decreased in all types of treatment. Serum d-ROM levels were significantly decreased in the 0.20% LRP group, but not in the 0.05% LRP, 0.05% LQP, and 0.20% LQP groups. Serum BAP levels were significantly increased in the 0.05% LRP and 0.20% LRP groups, but not in the 0.05% LQP and 0.20% LQP groups. Immunoblotting analysis revealed that the expression of phospho-AMPK was increased whereas that of phospho-ACC was decreased in the 0.20% LQP group. In conclusion, we demonstrated that both LRP and LQP alleviated the severity of NASH in a high-fat diet-induced NASH mouse model. In addition, we showed that LRP and LQP modulated oxidative stress and upregulated AMPK/ACC, respectively. Thus, LRP and LQP may constitute clinically applicable therapeutic agents for NASH. FAU - Kawaguchi, Takumi AU - Kawaguchi T AD - Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan. FAU - Ueno, Takato AU - Ueno T AD - Asakura Medical Association Hospital, Asakura, Japan. FAU - Nogata, Yoichi AU - Nogata Y AD - NARO Western Region Agricultural Research Center, Kagawa, Japan. FAU - Hayakawa, Masako AU - Hayakawa M AD - Liver Cancer Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, Japan. FAU - Koga, Hironori AU - Koga H AD - Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan. FAU - Torimura, Takuji AU - Torimura T AD - Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan. LA - eng PT - Journal Article DEP - 20161214 PL - Greece TA - Int J Mol Med JT - International journal of molecular medicine JID - 9810955 RN - 0 (Amino Acids, Branched-Chain) RN - 0 (Antioxidants) RN - 0 (Peptides) RN - 0 (Reactive Oxygen Species) RN - EC 2.7.11.31 (AMP-Activated Protein Kinases) RN - EC 6.4.1.2 (Acetyl-CoA Carboxylase) SB - IM MH - AMP-Activated Protein Kinases/*metabolism MH - Acetyl-CoA Carboxylase/*metabolism MH - Amino Acids, Branched-Chain/*metabolism MH - Animals MH - Antioxidants/metabolism MH - Body Weight MH - Diet, High-Fat/*adverse effects MH - Disease Models, Animal MH - Liver/metabolism/pathology MH - Male MH - Mice MH - Non-alcoholic Fatty Liver Disease/*etiology/*metabolism/pathology MH - *Oxidative Stress MH - Peptides/chemistry/metabolism MH - Reactive Oxygen Species/metabolism MH - Triticum/chemistry EDAT- 2016/12/22 06:00 MHDA- 2017/03/17 06:00 CRDT- 2016/12/22 06:00 PHST- 2016/06/27 00:00 [received] PHST- 2016/12/12 00:00 [accepted] PHST- 2016/12/22 06:00 [pubmed] PHST- 2017/03/17 06:00 [medline] PHST- 2016/12/22 06:00 [entrez] AID - 10.3892/ijmm.2016.2831 [doi] PST - ppublish SO - Int J Mol Med. 2017 Feb;39(2):407-414. doi: 10.3892/ijmm.2016.2831. Epub 2016 Dec 14.